Study 4 of 21 for search of: dimebon alzheimer's
Previous Study Return to Search Results Next Study

Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil (CONCERT)
This study is currently recruiting participants.
Verified by Medivation, Inc., January 2010
First Received: January 23, 2009   Last Updated: January 20, 2010   History of Changes
Sponsor: Medivation, Inc.
Collaborator: Pfizer
Information provided by: Medivation, Inc.
ClinicalTrials.gov Identifier: NCT00829374
  Purpose

The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.


Condition Intervention Phase
Alzheimer's Disease
Drug: Dimebon
Drug: Placebo comparator
Phase III

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease on Donepezil

Resource links provided by NLM:


Further study details as provided by Medivation, Inc.:

Primary Outcome Measures:
  • Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) [ Time Frame: Week 52 ] [ Designated as safety issue: No ]
  • Alzheimer's Disease Assessment Scale - Cognitive Subscale [ Time Frame: Week 52 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Clinician's Interview Based Impression of Change, plus caregiver input (CIBIC-plus) [ Time Frame: Week 52 ] [ Designated as safety issue: No ]
  • Neuropsychiatric Inventory (NPI) [ Time Frame: Week 52 ] [ Designated as safety issue: No ]
  • Resource Utilization in Dementia Lite (RUD lite) [ Time Frame: Week 52 ] [ Designated as safety issue: No ]
  • Euro Quality of Life 5 (EQ-5D) [ Time Frame: Week 52 ] [ Designated as safety issue: No ]

Estimated Enrollment: 1050
Study Start Date: March 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Dimebon, 5 mg orally three times daily
Drug: Dimebon
5 mg orally three times daily
2: Experimental
Dimebon, 20 mg orally three times daily
Drug: Dimebon
20 mg orally three times daily
3: Placebo Comparator
placebo orally three times daily
Drug: Placebo comparator
Placebo orally three times daily

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Mild-to-moderate Alzheimer's disease
  • Probable AD (DSM-IV-TR)
  • MMSE score between 12 and 24, inclusive
  • Stable on donepezil for at least 6 months

Exclusion Criteria:

  • Other causes of dementia
  • Major structural brain disease
  • Unstable medical condition or significant hepatic or renal disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00829374

Contacts
Contact: Anthony Golsorkhi, MD 415-829-4196 anthony.golsorkhi@medivation.com
Contact: Stewart Hallett, MBA 415-829-4113 stewart.hallett@medivation.com

  Hide Study Locations
Locations
United States, Arizona
Recruiting
Phoenix, Arizona, United States, 85006
Recruiting
Sun City, Arizona, United States, 85351
Recruiting
Tucson, Arizona, United States, 85724
United States, California
Recruiting
Costa Mesa, California, United States, 92626
Recruiting
Encino, California, United States, 91316
Recruiting
Escondido, California, United States, 92025
Recruiting
Fresno, California, United States, 93720
Recruiting
Garden Grove, California, United States, 92845
Recruiting
La Jolla, California, United States, 92037
Recruiting
Los Alamitos, California, United States, 90720
Recruiting
Los Angeles, California, United States, 90095
Recruiting
Martinez, California, United States, 94553
Recruiting
Newport, California, United States, 92660
Recruiting
Paramount, California, United States, 90723
Recruiting
Pasadena, California, United States, 91105
Recruiting
San Diego, California, United States, 92103
Recruiting
San Francisco, California, United States, 94143
United States, Colorado
Recruiting
Boulder, Colorado, United States, 80304
Recruiting
Denver, Colorado, United States, 80218
United States, Connecticut
Recruiting
New Haven, Connecticut, United States, 06510
United States, District of Columbia
Recruiting
Washington, District of Columbia, United States, 20057
United States, Florida
Recruiting
Deerfield Beach, Florida, United States, 33064
Recruiting
Delray Beach, Florida, United States, 33445
Recruiting
Jacksonville, Florida, United States, 32224
Recruiting
Miami, Florida, United States, 33137
Recruiting
Orlando, Florida, United States, 32806
United States, Georgia
Recruiting
Atlanta, Georgia, United States, 30329
United States, Hawaii
Recruiting
Honolulu, Hawaii, United States, 96814
United States, Indiana
Recruiting
Indianapolis, Indiana, United States, 46260
United States, Kentucky
Recruiting
Lexington, Kentucky, United States, 40536
United States, Maryland
Recruiting
Eaton, Maryland, United States, 21601
United States, Massachusetts
Recruiting
Boston, Massachusetts, United States, 02118
United States, Michigan
Recruiting
Ann Arbor, Michigan, United States, 48105
United States, Nevada
Recruiting
Las Vegas, Nevada, United States, 89106
United States, New Jersey
Recruiting
Mt Arlington, New Jersey, United States, 07865
Recruiting
Princeton, New Jersey, United States, 08540
United States, New York
Recruiting
Albany, New York, United States, 12208
Recruiting
Cedarhurst, New York, United States, 11516
Recruiting
New York, New York, United States, 10029
Recruiting
Rochester, New York, United States, 14620
United States, North Carolina
Recruiting
Durham, North Carolina, United States, 27710
United States, Ohio
Recruiting
Beachwood, Ohio, United States, 44122
Recruiting
Toledo, Ohio, United States, 43623
United States, Pennsylvania
Recruiting
Jenkintown, Pennsylvania, United States, 19046
Recruiting
Norristown, Pennsylvania, United States, 19401
United States, Rhode Island
Recruiting
Providence, Rhode Island, United States, 02906
United States, Texas
Recruiting
Austin, Texas, United States, 78757
Recruiting
Houston, Texas, United States, 77030
Recruiting
San Antonio, Texas, United States, 78229
United States, Virginia
Recruiting
Charlottesville, Virginia, United States, 22903
United States, Washington
Recruiting
Seattle, Washington, United States, 98108
United States, Wisconsin
Recruiting
Middleton, Wisconsin, United States, 53562
Australia, New South Wales
Recruiting
Newcastle, New South Wales, Australia
Recruiting
Sydney, New South Wales, Australia
Australia, Queensland
Recruiting
Brisbane, Queensland, Australia
Australia, South Australia
Recruiting
Adelaide, South Australia, Australia
Australia, Victoria
Recruiting
Geelong, Victoria, Australia
Recruiting
Melbourne, Victoria, Australia
Australia, Western Australia
Recruiting
Perth, Western Australia, Australia
Belgium
Recruiting
Antwerp, Belgium
Recruiting
Leuven, Belgium
Recruiting
Sint-Truiden, Belgium
Finland
Recruiting
Kuppio, Finland
Recruiting
Oulu, Finland
Recruiting
Turku, Finland
France
Recruiting
Bordeaux, France
Recruiting
Concert, France
Recruiting
Lille, France
Recruiting
Montpellier, France
Recruiting
Nice, France
Recruiting
Toulouse, France
Germany
Recruiting
Berlin, Germany
Recruiting
Bochum, Germany
Recruiting
Freiburg, Germany
Recruiting
Hattingen, Germany
Recruiting
Mannheim, Germany
Recruiting
Munich, Germany
Italy
Recruiting
Brescia, Italy
Recruiting
Florence, Italy
Recruiting
Genoa, Italy
Recruiting
Perugia, Italy
Recruiting
Rome, Italy
New Zealand, Canterbury
Recruiting
Christchurch, Canterbury, New Zealand
New Zealand
Recruiting
Auckland, New Zealand
Sweden
Recruiting
Malmo, Sweden
Recruiting
Norrkoping, Sweden
Recruiting
Stockholm, Sweden
United Kingdom, Middlesex
Recruiting
Brentford, Middlesex, United Kingdom
United Kingdom, Northhamptonshire
Recruiting
Rushden, Northhamptonshire, United Kingdom
United Kingdom, Scotland
Recruiting
Glasgow, Scotland, United Kingdom
United Kingdom, West Sussex
Recruiting
Worthington, West Sussex, United Kingdom
United Kingdom
Recruiting
Bath, United Kingdom
Recruiting
Blackpool, United Kingdom
Recruiting
Bradford, United Kingdom
Recruiting
Greater Manchester, United Kingdom
Recruiting
London, United Kingdom
Recruiting
Newcastle Upon Tyne, United Kingdom
Recruiting
Norfolk, United Kingdom
Recruiting
Oxford, United Kingdom
Recruiting
Southampton, United Kingdom
Recruiting
Swindon, United Kingdom
Sponsors and Collaborators
Medivation, Inc.
Pfizer
  More Information

No publications provided

Responsible Party: Medivation, Inc. ( Andria Langenberg, MD / Vice President, Clinical Development )
ClinicalTrials.gov Identifier: NCT00829374     History of Changes
Other Study ID Numbers: DIM18
Study First Received: January 23, 2009
Last Updated: January 20, 2010
Health Authority: United States: Food and Drug Administration

Keywords provided by Medivation, Inc.:
Alzheimer's disease
clinical trial
mitochondria
memory loss
neurodegenerative disease
dementia
investigational drug

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Donepezil
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs
Nootropic Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on September 01, 2010